Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases 2013-10-01

Clinical features of Pompe disease.

Fiore Manganelli, Lucia Ruggiero

Index: Acta Myol. 32(2) , 82-4, (2013)

Full Text: HTML

Abstract

Glycogen storage disease type II - also called Pompe disease or acid maltase deficiency - is an autosomal recessive metabolic disorder, caused by an accumulation of glycogen in the lysosome due to deficiency of the lysosomal acid alpha-glucosidase enzyme. Pompe disease is transmitted as an autosomal recessive trait and is caused by mutations in the gene encoding the acid α-glucosidase (GAA), located on chromosome 17q25.2-q25.3. The different disease phenotypes are related to the levels of residual GAA activity in muscles. The clinical spectrum ranging from the classical form with early onset and severe phenotype to not-classical form with later onset and milder phenotype is described.

Related Compounds

  • α-Glucosidase
  • Glycogen

Related Articles:

In vitro and in vivo effects of standardized extract and fractions of Phaleria macrocarpa fruits pericarp on lead carbohydrate digesting enzymes.

2013-01-01

[BMC Complement Altern. Med. 13 , 39, (2013)]

Enzymatic properties of a thermostable α-glucosidase from acidothermophilic crenarchaeon Sulfolobus tokodaii strain 7.

2013-01-01

[J. Microbiol. Biotechnol. 23(1) , 56-63, (2013)]

Identification of the first deletion-insertion involving the complete structure of GAA gene and part of CCDC40 gene mediated by an Alu element.

2013-04-25

[Gene 519(1) , 169-72, (2013)]

Detection of a novel mutation in the GAA gene in an Iranian child with glycogen storage disease type II.

2013-02-01

[Arch. Iran. Med. 16(2) , 126-8, (2013)]

In vitro anti-diabetic activity of Sclerocarya birrea and Ziziphus mucronata.

2013-09-01

[Nat. Prod. Commun. 8(9) , 1279-84, (2013)]

More Articles...